Tachocombe, sponge 4.8x 4.8x 0.5 cm 2 pcs

Tachocombe has a hemostatic, adsorptive effect. Substrate (fibrinogen) and catalytic (thrombin, etc.) activates blood clotting.

Pharmacodynamics

The plate adheres to the wound surface by polymerization, lasting 3-5 minutes and creating strong adhesion.

In contact with a bleeding wound or body fluids, the clotting factors in the covering layer of the plate – fibrinogen, thrombin, etc. – are released; by the action of the plate, the clotting factors are released. – are released; under the action of thrombin fibrinogen is converted into fibrin, aprotinin inhibits plasmin and inhibits fibrinolysis, a solid clot is formed. The plate itself is resorbed and subsequently (after 3-6 weeks) is replaced by connective tissue.

Indications

various bleedings, operations on the liver, spleen, etc.

Pharmacological effect

Tachocomb has a hemostatic and adsorbing effect. Substrate (fibrinogen) and catalytically (thrombin, etc.) activates blood clotting.

Pharmacodynamics

The plate adheres to the wound surface due to polymerization, which lasts 3–5 minutes and creates strong adhesion.

Upon contact with a bleeding wound or body fluids, the coagulation factors contained in the covering layer of the plate – fibrinogen, thrombin, etc. – are released; under the influence of thrombin, fibrinogen is converted into fibrin, aprotinin inhibits plasmin and inhibits fibrinolysis, and a strong clot is formed. The plate itself resolves and is subsequently (after 3–6 weeks) replaced by connective tissue.

Active ingredient

Fibrinogen, thrombin

Composition

1 sq. cm. sponges contains:

Active ingredients:

fibrinogen 5.5 mg,

thrombin 2 IU;

Excipients:

albumen,

arginine hydrochloride,

collagen,

sodium chloride,

sodium citrate,

riboflavin.

Contraindications

Hypersensitivity.

Side Effects

Possible increase in body temperature.

Storage conditions

At a temperature not exceeding 25 °C.

Shelf life

3 years.

Manufacturer

Takeda Austria GmbH, Austria